Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Basem Kildani

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Clinical Colorectal Cancer|November 28, 2008
Colorectal cancer treatment in elderly patients: an update on recent clinical studiesFederica Merlin, Tiziana Prochilo, Luca Tondulli, et al.
Acta Oncologica (Stockholm, Sweden)|September 14, 2007
Secondary acute lymphoblastic leukaemia following oxaliplatin for adjuvant chemotherapy in colon cancerFederica Merlin, Tiziana Prochilo, Basem Kildani, et al.
Critical Reviews in Oncology/Hematology|February 9, 2010
Colon cancerRoberto Labianca, Giordano D Beretta, Basem Kildani, et al.
Oncology|September 15, 2007
Feasibility of sequential therapy with FOLFIRI followed by docetaxel/cisplatin in patients with radically resected gastric adenocarcinoma. A randomized phase III trialMaria Di Bartolomeo, Roberto Buzzoni, Luigi Mariani, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Clinical Colorectal Cancer|November 28, 2008
Colorectal cancer treatment in elderly patients: an update on recent clinical studiesFederica Merlin, Tiziana Prochilo, Luca Tondulli, et al.
Acta Oncologica (Stockholm, Sweden)|September 14, 2007
Secondary acute lymphoblastic leukaemia following oxaliplatin for adjuvant chemotherapy in colon cancerFederica Merlin, Tiziana Prochilo, Basem Kildani, et al.
Critical Reviews in Oncology/Hematology|February 9, 2010
Colon cancerRoberto Labianca, Giordano D Beretta, Basem Kildani, et al.
Oncology|September 15, 2007
Feasibility of sequential therapy with FOLFIRI followed by docetaxel/cisplatin in patients with radically resected gastric adenocarcinoma. A randomized phase III trialMaria Di Bartolomeo, Roberto Buzzoni, Luigi Mariani, et al.
Pageof 1